The At3g09480 gene encodes HTB7, a histone H2B variant classified as part of Class II-B in Arabidopsis . Histone H2B is a core component of nucleosomes, which package DNA into chromatin. Variants like HTB7 play specialized roles in chromatin remodeling, transcriptional regulation, and stress responses .
Key Features of the Antibody:
The At3g09480 antibody enables precise detection of HTB7 in experimental systems, facilitating studies on:
Nucleosome Stability: HTB7 influences chromatin compaction and DNA accessibility. Antibody-based assays (e.g., ChIP-seq) can map HTB7 localization across the genome .
Histone Acetylation: Co-localization with acetylated histones (e.g., H3K9ac) reveals regulatory regions .
Environmental Adaptation: HTB7 may participate in chromatin remodeling during stress (e.g., drought, temperature changes) .
Gene Expression: Antibody-mediated detection of HTB7 in stress-responsive genes (e.g., RD29A) could elucidate its role in transcriptional activation .
Cell Differentiation: Histone variants like HTB7 are implicated in developmental transitions. The antibody aids in tracking HTB7 during tissue differentiation .
A. Antibody Specificity
The At3g09480 antibody is validated for use in:
| Method | Dilution | Notes |
|---|---|---|
| Western Blot | Supplier-specific | Detects HTB7 in protein extracts; requires optimization per protocol |
| IHC/IF | Supplier-specific | Localizes HTB7 in cellular compartments (nucleus, cytoplasm) |
| Variant | Gene ID | Class | Function |
|---|---|---|---|
| HTB1 | At1g07790 | I-A | Basal transcription, replication |
| HTB2 | At5g22880 | I-B | DNA repair, stress response |
| HTB7 | At3g09480 | II-B | Chromatin remodeling, nucleosome stability |
| HTB5 | At2g37470 | II-A | Transcriptional elongation |
Dilution Protocols: Exact dilution factors for WB/IHC are not publicly disclosed, requiring consultation with the supplier .
Cross-Reactivity: No data on cross-reactivity with non-Arabidopsis species (e.g., Oryza sativa) is available .
Functional Insights: Research gaps remain in linking HTB7 to specific transcription factors or epigenetic modifiers .
At3g09480 is an Arabidopsis thaliana gene that encodes a specific protein of interest to plant biologists. Understanding the target protein's characteristics is essential before utilizing antibodies for detection or localization studies. The gene is part of the Arabidopsis genome, which has been fully sequenced and annotated, allowing researchers to study protein expression and function systematically. When designing experiments with the corresponding antibody, researchers should consider the protein's predicted molecular weight, domains, and potential post-translational modifications that might affect antibody recognition .
Validating antibody specificity is a critical step before using it in experiments. For At3g09480 antibody, researchers should perform Western blot analysis using both wild-type Arabidopsis and corresponding mutant lines (preferably knockout mutants). A specific antibody will show a band of the expected molecular weight in wild-type samples that is absent or altered in the mutant. Additionally, immunocytochemistry or immunohistochemistry can be performed in both wild-type and mutant tissues to confirm specificity in situ. As demonstrated with other Arabidopsis antibodies like AXR4, ACO2, AtBAP31, and ARF19, validation against respective mutant backgrounds provides definitive evidence of specificity .
For optimal results with At3g09480 antibody in Western blot applications, follow these methodological steps:
Harvest fresh Arabidopsis tissue (preferably the tissue where At3g09480 is expressed)
Grind tissue in liquid nitrogen to a fine powder
Extract proteins using an appropriate buffer (typically containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitors)
Centrifuge at 13,000 × g for 15 minutes at 4°C
Collect supernatant and quantify protein concentration
Separate proteins by SDS-PAGE (10-12% gel recommended)
Transfer to PVDF or nitrocellulose membrane
Block with 3-5% BSA or non-fat dry milk in TBST
Incubate with affinity-purified At3g09480 antibody (optimal dilution must be determined empirically, typically 1:250 to 1:1000)
Wash and incubate with appropriate secondary antibody
Detect using chemiluminescence or other detection methods
Research has shown that affinity purification of antibodies significantly improves detection rates, with studies demonstrating an increase from low success rates to 55% detection with high confidence after purification .
For immunolocalization of the At3g09480 protein in plant tissues, follow this methodological approach:
Fix tissue samples in 4% paraformaldehyde for 30 minutes
Wash twice with PBS
Block with 5% goat serum, 1% BSA, 0.2% Triton X-100 for 1 hour at 4°C
Incubate overnight at room temperature with purified At3g09480 antibody (dilution 1:25 to 1:250, depending on antibody quality)
Wash with PBS (3 × 10 minutes)
Incubate with fluorescently-labeled secondary antibody
Counterstain nuclei if desired
Mount slides with anti-fade mounting medium
Observe using confocal microscopy
This protocol is based on established methods for Arabidopsis antibodies that have been shown to successfully detect proteins at subcellular, cellular, and tissue levels .
For quantitative assessment of At3g09480 protein expression, researchers should employ a systematic approach combining Western blot analysis with appropriate controls and quantification methods:
Ensure equal loading of protein samples (20-50 μg) from different tissues/conditions
Include internal loading controls (e.g., anti-actin or anti-tubulin antibodies)
Perform technical replicates (minimum three) and biological replicates (minimum three)
Use a standard curve with recombinant protein if absolute quantification is required
Employ densitometry software for quantification of band intensities
Normalize target protein signal to loading control signal
Perform statistical analysis (ANOVA or t-test depending on experimental design)
Table 1: Example quantification workflow for At3g09480 protein expression analysis
| Step | Method | Key Considerations |
|---|---|---|
| Sample preparation | Tissue-specific extraction | Maintain consistent extraction conditions |
| Protein quantification | Bradford/BCA assay | Generate standard curve with BSA |
| Gel loading | Equal amounts per lane | Include ladder and positive control |
| Transfer | Semi-dry or wet transfer | Verify transfer efficiency with Ponceau S |
| Immunodetection | Primary + secondary antibody | Include no-primary antibody control |
| Imaging | Chemiluminescence | Avoid saturation of signal |
| Quantification | Densitometry | Background subtraction |
| Data analysis | Normalization to control | Statistical validation |
This methodological approach allows for robust comparison of At3g09480 protein levels across experimental conditions, providing insights into its regulation and expression patterns .
Cross-reactivity can be a significant challenge when working with plant antibodies, especially if the target protein belongs to a multi-gene family. To address potential cross-reactivity with the At3g09480 antibody:
Epitope mapping: Determine the exact epitope recognized by the antibody through peptide array analysis or epitope extraction and mass spectrometry
Absorption controls: Pre-incubate the antibody with excess purified antigen or synthetic peptide before immunodetection to confirm specificity
Knockout validation: Test the antibody in knockout or knockdown lines for At3g09480 and related family members
Peptide competition assay: Compare antibody binding with and without competing peptide
Alternative antibody generation: If necessary, design new antibodies against more unique regions of the protein
Research has shown that careful bioinformatic analysis to identify potential antigenic regions with less than 40% sequence similarity to other proteins significantly reduces cross-reactivity issues. When this approach is not possible, researchers may need to accept a family-specific antibody rather than one specific to a single protein .
Immunoprecipitation (IP) is a powerful technique for investigating protein-protein interactions. For At3g09480, optimize your IP protocol with these methodological considerations:
Extraction buffer optimization:
Test different buffer compositions (varying salt concentrations, detergents)
Include protease inhibitors and phosphatase inhibitors if phosphorylation is relevant
Consider native versus denaturing conditions based on research questions
Antibody coupling:
Covalently couple purified At3g09480 antibody to protein A/G beads using crosslinkers
Determine optimal antibody-to-bead ratio (typically 5-10 μg antibody per 50 μl bead slurry)
Include IgG control for non-specific binding assessment
IP procedure:
Pre-clear lysate with protein A/G beads to reduce background
Optimize antibody incubation time (4 hours to overnight)
Determine optimal washing stringency to remove non-specific interactions
Elution and analysis:
Use mild elution for maintaining protein-protein interactions
More stringent elution for maximum recovery of target protein
Analyze by mass spectrometry or Western blotting
Table 2: Troubleshooting guide for At3g09480 immunoprecipitation
| Issue | Potential Cause | Solution |
|---|---|---|
| Low target protein recovery | Insufficient binding | Increase antibody amount or incubation time |
| Harsh washing conditions | Reduce salt concentration or detergent in wash buffer | |
| Protein degradation | Add additional protease inhibitors | |
| High background | Insufficient washing | Increase wash stringency or number of washes |
| Non-specific antibody binding | Pre-clear lysate and use higher quality antibody | |
| No interacting partners detected | Weak or transient interactions | Use crosslinking reagents before lysis |
| Inappropriate buffer conditions | Optimize buffer composition for interaction stability |
Following this methodological approach will maximize the chances of successfully identifying true interacting partners of the At3g09480 protein .
Researchers occasionally encounter discrepancies between protein levels detected by antibodies and mRNA levels measured by techniques like RT-PCR or RNA-seq. To address such contradictions with At3g09480:
Verify antibody specificity:
Confirm the antibody recognizes the correct protein through knockout validation
Test antibody recognition of recombinant At3g09480 protein
Perform epitope mapping to ensure antibody binds the expected region
Consider post-transcriptional regulation:
Assess mRNA stability through actinomycin D chase experiments
Investigate potential miRNA-mediated regulation of At3g09480 transcripts
Examine alternative splicing patterns that might affect antibody recognition
Evaluate post-translational regulation:
Test for protein degradation rates using cycloheximide chase assays
Investigate potential post-translational modifications affecting antibody binding
Consider subcellular localization changes that might affect extraction efficiency
Technical validation:
Use multiple antibodies recognizing different epitopes of At3g09480
Employ complementary techniques like mass spectrometry for protein quantification
Ensure RNA quality and consider using multiple reference genes for normalization
This systematic approach helps determine whether discrepancies reflect biological phenomena or technical limitations, providing insights into the regulation of At3g09480 expression .
For researchers interested in potential DNA-binding properties of At3g09480 or its association with chromatin, ChIP protocols can be adapted with the following methodological considerations:
Crosslinking optimization:
Test different formaldehyde concentrations (0.5-3%)
Optimize crosslinking time (5-20 minutes)
Consider dual crosslinking with DSG followed by formaldehyde for improved efficiency
Chromatin preparation:
Optimize sonication parameters to achieve 200-500 bp fragments
Verify fragmentation efficiency by agarose gel electrophoresis
Pre-clear chromatin with protein A/G beads to reduce background
Immunoprecipitation:
Determine optimal antibody amount through titration experiments
Include appropriate controls (input, IgG control, positive control antibody)
Extend incubation time (overnight at 4°C recommended)
Washing and elution:
Use increasingly stringent wash buffers
Elute DNA-protein complexes with elution buffer containing SDS
Reverse crosslinks and purify DNA for downstream analysis
Analysis options:
qPCR for candidate regions
ChIP-seq for genome-wide binding profile
Cut&Run or CUT&Tag as alternative approaches with potentially higher sensitivity
This methodological framework allows researchers to investigate whether At3g09480 associates with specific DNA regions, providing insights into potential regulatory functions .
When comparing peptide versus recombinant protein approaches for generating At3g09480 antibodies, consider these important differences:
Peptide antibodies:
Target short amino acid sequences (typically 10-20 residues)
Can be designed to recognize specific regions (e.g., modified sites)
Generally lower success rate (particularly poor for plant proteins)
May have limited utility in applications requiring native protein recognition
Recombinant protein antibodies:
Target larger protein fragments or domains
Recognize multiple epitopes on the target protein
Higher success rate for detection in multiple applications
Better recognition of native protein conformations
Research on Arabidopsis antibodies has shown that the success rate with peptide antibodies is very low, while antibodies raised against recombinant proteins performed significantly better. Studies demonstrated that of 70 recombinant protein antibodies tested, 38 (55%) could detect signals with high confidence, and 22 were suitable for immunocytochemistry applications .
For At3g09480 specifically, a recombinant protein approach targeting unique antigenic regions (with <40% sequence similarity to other proteins) would likely yield better results for multiple applications including Western blot, immunoprecipitation, and immunolocalization studies.
Recent methodological advances have significantly enhanced detection of low-abundance plant proteins, which is particularly relevant for At3g09480 if it is not highly expressed:
Signal amplification techniques:
Tyramide signal amplification (TSA) for immunohistochemistry
Proximity ligation assay (PLA) for protein interaction studies
Enhanced chemiluminescence substrates for Western blot
Sample preparation improvements:
Optimized extraction buffers for specific cellular compartments
Subcellular fractionation to concentrate target proteins
Immunoprecipitation before detection to enrich low-abundance targets
Antibody engineering:
Affinity purification against specific recombinant antigens
Monoclonal antibody development for increased specificity
Recombinant antibody fragments with enhanced tissue penetration
Table 3: Comparison of detection methods for low-abundance plant proteins
| Detection Method | Sensitivity | Advantages | Limitations |
|---|---|---|---|
| Standard Western blot | ng range | Simple, widely accessible | Limited sensitivity |
| ECL-Advanced Western | pg range | Higher sensitivity, wide dynamic range | More expensive reagents |
| TSA-enhanced immunofluorescence | Single molecule | Dramatic signal amplification | Potential background issues |
| Mass spectrometry | ng-pg range | Unbiased detection | Expensive equipment, complex analysis |
| PLA | Single molecule | In situ detection of interactions | Requires two antibodies to different epitopes |
Research has demonstrated that affinity purification of antibodies "massively improved the detection rate" for Arabidopsis proteins. These methodological advances have transformed how researchers detect and study low-abundance plant proteins in complex biological samples .
Non-specific background is a common challenge in immunolocalization studies. For At3g09480 antibody, implement these methodological approaches to improve signal-to-noise ratio:
Antibody optimization:
Titrate antibody concentration to find optimal dilution
Affinity-purify antibody against recombinant At3g09480 protein
Pre-adsorb with plant tissue from knockout mutants
Blocking optimization:
Test different blocking agents (BSA, normal serum, commercial blockers)
Increase blocking time and concentration
Add 0.1-0.3% Triton X-100 to reduce hydrophobic interactions
Sample preparation refinement:
Optimize fixation conditions (time, temperature, fixative)
Improve tissue permeabilization
Consider antigen retrieval methods if applicable
Controls implementation:
Include no-primary antibody control
Use tissue from knockout mutants as negative control
Pre-incubate antibody with immunizing peptide/protein
Apply secondary antibody alone to assess non-specific binding
Detection optimization:
Use fluorophores with minimal plant autofluorescence overlap
Apply shorter exposure times with more sensitive cameras
Employ confocal microscopy for improved signal resolution
By systematically optimizing these parameters, researchers can significantly improve the specificity of At3g09480 immunolocalization. Studies on Arabidopsis antibodies have shown that stringent validation and optimization are essential for successful immunocytochemistry applications .
Determining optimal working conditions for the At3g09480 antibody requires systematic optimization:
Antibody titration:
For Western blot: Test serial dilutions (1:100 to 1:5000)
For immunolocalization: Test dilutions from 1:25 to 1:500
For ELISA: Perform checkerboard titration (antibody vs. antigen)
Incubation time and temperature:
Compare different incubation times (1 hour, overnight)
Test various temperatures (4°C, room temperature, 37°C)
Determine optimal conditions for signal-to-noise ratio
Buffer composition:
Test different diluents (TBS, PBS, with various detergents)
Vary blocking agent concentration (1-5% BSA or milk)
Add stabilizers if needed (glycerol, carrier proteins)
Table 4: Example optimization matrix for Western blot applications
| Antibody Dilution | 1 hr RT | 2 hr RT | Overnight 4°C |
|---|---|---|---|
| 1:100 | High background | Moderate background | Specific but strong |
| 1:500 | Moderate signal | Good signal | Optimal signal |
| 1:1000 | Weak signal | Detectable signal | Good signal |
| 1:5000 | No signal | Very weak signal | Weak signal |
Integrating At3g09480 antibody into quantitative proteomics workflows offers powerful approaches for studying protein abundance, modifications, and interactions:
Immunoprecipitation-mass spectrometry (IP-MS):
Use At3g09480 antibody to enrich the target protein and interacting partners
Process samples for LC-MS/MS analysis
Implement label-free or isotopic labeling approaches (SILAC, TMT) for quantification
Compare protein complexes across different conditions or treatments
Selected reaction monitoring (SRM):
Develop SRM assays for At3g09480-specific peptides
Use heavy-labeled peptide standards for absolute quantification
Monitor At3g09480 across tissues, developmental stages, or stress conditions
Proximity-dependent labeling:
Fuse At3g09480 to BioID or APEX2 for proximity labeling
Validate interactions by IP with At3g09480 antibody
Identify transient or weak interactions not detected by conventional IP
Post-translational modification mapping:
Immunoprecipitate At3g09480 using the specific antibody
Analyze by MS to identify phosphorylation, ubiquitination, or other modifications
Compare modification patterns across developmental or stress conditions
These approaches provide deeper insights into At3g09480 function than antibody detection alone, allowing researchers to place the protein within cellular networks and regulatory pathways .
Emerging technologies for single-cell protein analysis can be adapted for use with At3g09480 antibody in plant tissues:
Single-cell immunofluorescence:
Optimize tissue preparation to maintain cellular integrity
Use high-sensitivity confocal or super-resolution microscopy
Implement signal amplification (TSA) for low-abundance detection
Quantify fluorescence intensity across individual cells
Flow cytometry with plant protoplasts:
Generate protoplasts from plant tissues
Perform fixation and permeabilization
Stain with At3g09480 antibody and fluorescent secondary antibody
Analyze protein expression at single-cell resolution
Sort cells based on expression levels for downstream analysis
Mass cytometry (CyTOF):
Conjugate At3g09480 antibody with rare earth metals
Analyze single-cell protein expression in concert with other markers
Create high-dimensional profiles of plant cell types
In situ proximity ligation assay:
Use At3g09480 antibody paired with antibodies against potential interactors
Detect protein-protein interactions in individual cells
Quantify interaction frequency across cell types
These approaches allow researchers to move beyond tissue-level analysis to understand cell-type specific expression and functions of At3g09480, providing insights into its role in cellular differentiation and response to environmental stimuli .
Several emerging technologies promise to expand the utility of At3g09480 antibody for plant research:
Spatial transcriptomics integration:
Combine antibody-based protein detection with spatial transcriptomics
Correlate protein localization with gene expression patterns
Identify discrepancies between transcript and protein levels spatially
Microfluidic antibody analysis:
Develop microfluidic platforms for high-throughput antibody validation
Perform multiplexed antibody detection with minimal sample consumption
Automate optimization of antibody conditions
Machine learning for antibody design:
Implement biophysics-informed models to predict antibody specificity
Design custom antibodies with desired specificity profiles
Predict epitopes that maximize detection across multiple applications
Disentangle binding modes associated with specific ligands
Nanobody and alternative binding reagents:
Develop single-domain antibodies (nanobodies) against At3g09480
Create synthetic binding proteins with enhanced specificity
Engineer aptamers as alternatives to traditional antibodies
In planta antibody expression:
Express intrabodies targeting At3g09480 in transgenic plants
Study protein function through in vivo perturbation
Create biosensors to monitor protein dynamics in living plants
These technological advances, particularly machine learning approaches for antibody design, show promise for creating antibodies with both specific and cross-specific binding properties, potentially addressing current limitations in plant antibody research .
Implementing systematic validation frameworks can significantly enhance reliability and reproducibility of research utilizing At3g09480 antibody:
Comprehensive validation checklist:
Confirm reactivity against recombinant protein
Verify absence of signal in knockout/knockdown lines
Test cross-reactivity with related family members
Validate in multiple applications (Western, IP, ICC)
Document all validation experiments with appropriate controls
Standardized reporting:
Adopt minimum information guidelines for antibody experiments
Document key parameters (catalog number, lot, dilution, incubation)
Share validation data through repositories or supplementary materials
Report negative results to build community knowledge
Independent validation:
Engage third-party laboratories for blinded validation
Use orthogonal methods to confirm antibody-based findings
Implement interlaboratory studies to assess reproducibility
Community resources:
Contribute validation data to antibody databases
Share protocols through platforms like protocols.io
Deposit antibody-producing hybridomas in repositories
By adopting these systematic validation approaches, researchers can enhance confidence in At3g09480 antibody applications and build a more robust foundation for plant proteomics research. As demonstrated with other Arabidopsis antibodies, rigorous validation significantly improves detection reliability and enables more sophisticated applications in protein research .
Researchers seeking validated antibodies for Arabidopsis proteins including At3g09480 have several resource options:
Academic repositories:
The Nottingham Arabidopsis Stock Centre provides access to validated Arabidopsis antibodies
The Arabidopsis Biological Resource Center may offer antibody resources
Academic laboratories with expertise in At3g09480 research
Commercial sources:
Specialized plant research antibody suppliers
Custom antibody generation services with validation packages
Collaborative networks:
Plant community research collaborations
Consortia focused on plant proteomics
Resource sharing through material transfer agreements